BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

845 related articles for article (PubMed ID: 32311326)

  • 1. COVID-19 disrupts vaccine delivery.
    Nelson R
    Lancet Infect Dis; 2020 May; 20(5):546. PubMed ID: 32311326
    [No Abstract]   [Full Text] [Related]  

  • 2. Riding the coronacoaster of uncertainty.
    The Lancet Infectious Diseases
    Lancet Infect Dis; 2020 Jun; 20(6):629. PubMed ID: 32422202
    [No Abstract]   [Full Text] [Related]  

  • 3. Audio Interview: Covid-19 Vaccine Development.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2020 Jul; 383(3):e40. PubMed ID: 32668131
    [No Abstract]   [Full Text] [Related]  

  • 4. Covid-19 and the race for a vaccine.
    Cueto M
    Hist Cienc Saude Manguinhos; 2020; 27(3):715-717. PubMed ID: 33111785
    [No Abstract]   [Full Text] [Related]  

  • 5. COVID-19 vaccine development pipeline gears up.
    Mullard A
    Lancet; 2020 Jun; 395(10239):1751-1752. PubMed ID: 32505245
    [No Abstract]   [Full Text] [Related]  

  • 6. Next-generation vaccine platforms for COVID-19.
    van Riel D; de Wit E
    Nat Mater; 2020 Aug; 19(8):810-812. PubMed ID: 32704139
    [No Abstract]   [Full Text] [Related]  

  • 7. COVID-19: endgames.
    The Lancet Infectious Diseases
    Lancet Infect Dis; 2020 May; 20(5):511. PubMed ID: 32311325
    [No Abstract]   [Full Text] [Related]  

  • 8. The Race to Develop a COVID-19 Vaccine.
    Am J Nurs; 2020 Oct; 120(10):14-15. PubMed ID: 32976132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 therapies and vaccine landscape.
    Nat Mater; 2020 Aug; 19(8):809. PubMed ID: 32704138
    [No Abstract]   [Full Text] [Related]  

  • 10. Progress and Concept for COVID-19 Vaccine Development.
    Wu SC
    Biotechnol J; 2020 Jun; 15(6):e2000147. PubMed ID: 32304139
    [No Abstract]   [Full Text] [Related]  

  • 11. Challenges in evaluating SARS-CoV-2 vaccines during the COVID-19 pandemic.
    Abu-Raya B; Gantt S; Sadarangani M
    CMAJ; 2020 Aug; 192(34):E982-E985. PubMed ID: 32646869
    [No Abstract]   [Full Text] [Related]  

  • 12. Keeping track of the SARS-CoV-2 vaccine pipeline.
    Parker EPK; Shrotri M; Kampmann B
    Nat Rev Immunol; 2020 Nov; 20(11):650. PubMed ID: 32989290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 vaccines: no time for complacency.
    The Lancet
    Lancet; 2020 Nov; 396(10263):1607. PubMed ID: 33220729
    [No Abstract]   [Full Text] [Related]  

  • 14. [Not Available].
    Nau JY
    Rev Med Suisse; 2020 Jun; 16(696):1176-1177. PubMed ID: 32496711
    [No Abstract]   [Full Text] [Related]  

  • 15. Developing Covid-19 Vaccines at Pandemic Speed.
    Lurie N; Saville M; Hatchett R; Halton J
    N Engl J Med; 2020 May; 382(21):1969-1973. PubMed ID: 32227757
    [No Abstract]   [Full Text] [Related]  

  • 16. The Regulation of COVID-19 "Challenge" Studies.
    Menikoff J
    Am J Bioeth; 2020 Jul; 20(7):80-82. PubMed ID: 32716768
    [No Abstract]   [Full Text] [Related]  

  • 17. Ensuring global access to COVID-19 vaccines.
    Yamey G; Schäferhoff M; Hatchett R; Pate M; Zhao F; McDade KK
    Lancet; 2020 May; 395(10234):1405-1406. PubMed ID: 32243778
    [No Abstract]   [Full Text] [Related]  

  • 18. Possible treatment of Covid-19 with a therapeutic vaccine.
    Myint A; Jones T
    Vet Rec; 2020 Apr; 186(13):419. PubMed ID: 32245869
    [No Abstract]   [Full Text] [Related]  

  • 19. Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines: Setting Expectations Appropriately.
    Heininger U
    Pediatr Infect Dis J; 2020 Jul; 39(7):e123-e124. PubMed ID: 32427644
    [No Abstract]   [Full Text] [Related]  

  • 20. Sarah Gilbert: carving a path towards a COVID-19 vaccine.
    Lane R
    Lancet; 2020 Apr; 395(10232):1247. PubMed ID: 32305089
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 43.